Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-081698
Filing Date
2013-11-06
Accepted
2013-11-06 16:13:26
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19856_110q.htm 10-Q 917607
2 EX-31.1 a13-19856_1ex31d1.htm EX-31.1 11702
3 EX-32.1 a13-19856_1ex32d1.htm EX-32.1 5726
  Complete submission text file 0001104659-13-081698.txt   5968423

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT espr-20130930.xml EX-101.INS 537028
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20130930.xsd EX-101.SCH 76110
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20130930_cal.xml EX-101.CAL 47318
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20130930_lab.xml EX-101.LAB 1022399
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20130930_pre.xml EX-101.PRE 600523
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20130930_def.xml EX-101.DEF 398073
Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 131196598
SIC: 2834 Pharmaceutical Preparations